Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (41)	10/29/2014 1:01:45 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 136

>> Apparently, Xencor & Amgen do, too, a little bit. << Agreed. But I don't have a full position, and poor RA data might be a blessing. (Doesn't mean I'll jump at that/any op!) Regarding "boring".... today's world, a platform for producing humanized MAbs is a big yawn. There are ~20 groups aimed at the same-old, same-old checkpoint inhibitors (GITR, OX-40, etc.). I still believe that companies that can patent Fc tricks are takeover candidates. That sentiment, if widely shared, might take some volatility out of trading. But I'm with you, and expected more low-volume volatility.